Microlab’s CARIPILL receives Emerging Brand of the Year at the 8th Annual Pharmaceutical Leadership Summit & Pharma leaders Business Leadership Awards 2015

Microlab’s CARIPILL receives Emerging Brand of the Year at the 8th Annual Pharmaceutical Leadership Summit & Pharma leaders Business Leadership Awards 2015

The 8th Annual Pharmaceutical Leadership Summit & Business Leadership Awards was successfully concluded at the financial capital of india in Mumbai at Hotel Hilton today where more than 300 top leaders of the healthcare industry had gathered to be the part of the historic debate on  “Pharma Leaders 2015, Brand India Winning”. Widely acclaimed in the healthcare industry as the pioneer in recognising the leaders of today & tomorrow, Pharma Leaders brought together veteran healthcare leaders under one plattform. The leadership Summit in the afternoon session debated crucial topics such as Healthcare Insurance, Medical Tourism, Challenges of Indian Pharma Industry. Microlab’s CARIPILL received the top recognition at the Pharma Leaders Power Brand Awards. Mr. Ashok Jain, Executive Director of Microlabs received the Trophy & Certificate of Excellence from Mr. Louis Banks who has often  been referred to as the Godfather of Indian Jazz & the iconic music composer was the Chief Guest of the evening conferred to top achievers of the country & urged the industry to provide affordable medicines to the common masses in india.

 Satya Brahma, founder of Pharmaleaders in the opening address lambasted the union government for the faulty healthcare reforms & policy paralysis. In a scathing attack to the policy makers, Satya said “the Healthcare Challenges in India at present are of different dimensions & more of cleaning the system at the helm who are responsible for formulating laws, rules & regulations. While we can’t ignore the concerns of the pharma companies facing complex issues in regulatory legal hurdles in IPR challenges, pricing &other issues related to patent regime. Pharmaleaders believe that the evolving global and domestic market dynamics are likely to result in significant opportunities and challenges for pharma companies operating in India, both Indian companies as well as Indian affiliates of MNC companies. Some key issue areas are already starting to capture the attention of leadership teams within the industry.


Bengaluru-based Micro Labs, a fully integrated pharma company recently launched Caripill, which helps to increase the platelet count in patients suffering from dengue.  Approved by the scientific and regulatory authority, the pill is made from Carica Papaya leaf extract and reportedly does not have any side-effects.  Being a product of extensive R&D and clinical trials conducted by Micro Labs, the pill has proved its safety and efficacy in about one lakh patients across India, claims a company release.

MicrolabsCaripill Syrup Pack shotCaripill Tablet Pack shot
Speaking about Caripill, Dr AC Gowda Fortis Hospital, Bangalore and Principal Investigator, Clinical Trial for Caripill said, “The encouraging results on the dengue patients has shown the immense potential of what Caripill is capable of, that eventually can be administered on patients with other life-threatening diseases, like leukaemia among others, which requires intense chemotherapy leading to loss of platelets.” He added, “After an extensive research across two years conducting clinical trials on 250 patients, we have seen positive results with a dramatic decrease in the haemorrhage condition, besides, none of the patients who are administered the drug have had to undergo blood transfusion so far.”

Caripill costs Rs 25 per tablet with the dosage of administering one pill (1100 mg) three times a day, for five days.

No specific treatment was available for treating dengue, except for some paracetamol tablets (mostly Dolo 650 by Micro Labs) to reduce the fever/ temperature. However, immediately post the fever reduces, the platelets count on blood starts falling leading to serious health consequences. Despite considerable efforts to control the mosquito population, dengue fever has emerged, spread and established itself rapidly. Looking into the limited current modalities of treatment and its affordability to a fewer sections of population, Caripill can be of considerable use.

Ashok Jain, Executive Director, Micro Labs, stated, “Over four decades, we have been successful in manufacturing oral solids, liquids, topical and injectable medication for patients across verticals – diabetology, cardiology, ophthalmology, dermatology, pain/analgesics, etc.  Today, I would like to congratulate our team at Micro Labs for making a remarkable breakthrough in treating moderate to severe dengue cases with the newly introduced Caripill that comes at an affordable cost.”

Dr Nagabhushan KH, VP-Medical Services, Micro Labs, stated, “At present, the popular treatment for dengue is by oral consumption of juice crudely extracted from the non-standardised and unhygienic papaya leaves with no clear dosage specified, that could have a detrimental impact on sufferers. Our new Caripill, has received positive feedback from doctors treating patients with dengue and are confident the usage of the pill can be further extended to treating patients with other life-threatening disorders that require restoration of blood platelets.”  He further added, “The rising number of dengue cases among children, has driven us to introduce a paediatric Caripill syrup for easy consumption and plan to launch it soon.”

Caripill has been made available in all major pharmacies across India.

Reportedly it doesn’t have any side effects. According to the clinical trials, Caripill has shown positive results. A plus point is, none of them had to undergo blood transfusion. And henceforth, they are thinking of utilizing in patients with leukemia who have thrombocytopenia post chemotherapy, in future. As far as I have come across, it costs 25/- per tablet. Presently if we see the limited modalities of treatment, and the fact that it can be afforded only by fewer strata of the society, I think yes, Caripill can be worth it. Yes, caripill has some questions before it is fully accepted as platelet booster. However, given the scenario of dengue where platelet transfusion is the only option for severe depletion, caripill is a worth trying drug. Totally chemical free, I do recommend its usage and have found it to be useful. It defenitely reduced the need for platelet transfusions in some but not in all., to me, it is a worth trying drug but make sure you take it only after your doctor suggests it.Yes Micro Labs has introduced Caripill which is tablet containing leaf extract of papaya (Carica Papaya Leaf extract). It is available in market and many doctors are prescribing & have found it to be useful. However, it is advised to be taken after discussing with your doctor. One should know when to start taking Caripill (ie at what level of platelet count) and doctors are best to judge. You can contact Micro Labs @ +919845855122 by sending a message with your details and a request to call back. Caripill Cell will call back with more information.


Established in 1973, Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations.
In  Indian Pharmaceutical Market, Micro labs is ranked 15th among prescriptions (as per SMSRC Jul’15) and 19th in sales (as per AWACS MAT Sep’ 15).The brand portfolio of Micro Labs includes some of the topmost brands in various specialties like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain, etc. Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management.Micro Labs is poised to achieve unparalleled status in the global pharmaceutical industry. Backed by a profound and resolute vision, we now have our eyes set on attaining the $1 billion mark by 2017.

Other accomplishments include:

  • Brand Dolo won ‘Best Managed Brand Award’ awarded by the Institute of Pharmaceutical Healthcare Management & Research’s conference in 2010
  • Dolo 650 was awarded as ‘Brand of the Year 2013’ at 6th Annual Pharmaceutical Leadership Summit 2013
  • Dolo 650 also won the Brand of the Year 2014 GOLD award and Amlong won Brand of the Year 2014 BRONZE Award at AWACS Marketing Excellence Awards 2014
  • Dilip Surana has been been honoured time and again with prestigious awards such as the ‘Dynamic Entrepreneur of the year 2010’, honoured as the Great Son of Karnataka’ by Governor of Karnataka his Excellency HR Bhardwaj in 2011
  • Dilip Surana has been bestowed with the title of ‘Most Dynamic Entrepreneur of the Year’ at 4th Annual India Leadership Conclave and Indian Affairs Business Leadership Awards 2013. He was also honoured as‘Entrepreneur of the Year 2014’ in the following year.
  • Micro Labs has also introduced a lot many number of formulations for the 1st time in the country like Anxit, Dolo-650,Silybon,Ebast and Caripill
  • Various manufacturing facilities of Micro Labs have bagged Quality Excellence awards consistently year after year

Milestones:

  • 19 specialty divisions,with a wide product range and a dedicated field force of 4500 plus.
  • 14 World class manufacturing facilities approved by various agencies including US FDA, UK-MHRA, MCC-South Africa, Health Canada, WHO, TGA Australia & Medsafe-New Zealand, with 2000 qualified technical personnel
  • A vibrant presence in over 40 countries, exporting formulations in all major therapeutic segments
  • Three R&D centres with more than 250 experienced scientists
  • GDA foundation runs the Surana College and Surana PG centre in Bangalore and “Smt. Pyaribai Chunnilalji Surana Charitable trust runs Shree Parshwa Susheel Dham”, a magnificent Jain temple in Attibele, Bangalore

The company is also at the forefront in social contribution, striving to be a model corporate citizen in terms of Social Initiatives with significant contributions in the areas of education and health.

Pharma Leaders Super Brand Award & Recognition to Top Hair Transplant & Cosmetic Plastic Surgeon Dr. Viral Desai

Pharma Leaders Super Brand Award & Recognition to Top Hair Transplant & Cosmetic Plastic Surgeon Dr. Viral Desai

 Eminent Hair Transplant & Cosmetic Plastic Surgeon voted by Network 7 Media Group Jury as “India’s Most Promising Hair Transplant Surgeon 2015” & “India’s most Admired Plastic & Cosmetic Surgeon 2015”

Noted Hair Transplant Surgeon who has been in news for bringing revolutionary treatment process in Hair Transplant & Cosmetic Plastic Surgery received the prestigious & coveted Award & Certificate of Excellence in two important categories such as “India’s Most Promising Hair Transplant Surgeon 2015” & “India’s most Admired Plastic & Cosmetic Surgeon 2015” from the hands of India’s top Music Composer & a living legend Louiz Banks with the presence of Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders, a leading media title in healthcare journalism.  Speaking to the media on receiving the recognition at the top healthcare platform, Dr. Viral Desai Aesthetic & Cosmetic Plastic, Laser, Reconstructive Surgeon & Medical Director at  DHI India, Medical Director – CPLSS said “It indeed is a great privilege and honor to be receiving the award where the top healthcare leaders of the country are present & this award reflects our efforts in the field of Hair Transplant Surgery & Cosmetic Plastic Surgery. Dr Viral Desai received the award at the platform where more than 300 healthcare leaders of the country were present in Mumbai on 30th December 2015. The ace Hair Transplant surgeon also presented a talk on “Patients First in Healthcare : the challenge of creating a new and improved Medicare”. The panel discussion on Will Innovations in India drive the next generation of global cosmetics Dermatology trends ? was acrtively participated by Dr Desai with top skincare leaders of the country such as Dr Manoj Khanna,Plastic Surgeon, Dr. Sumita Shankar, Plastic, Cosmetic & Wound Surgeon, Dr Nilyini G, Cosmetic Dermatologist, Founder, Blu Skin Cosmetology, Dr. Rashmi Shetty,Non-Surgical Aesthetic Medicine Expert , Dr. Poorva Shah,Cosmetic Dermatologist, Ms. Kiren Shrivastav, CEO & Founder, Molecule Communications.


About Dr. Viral Desai

Aesthetic & Cosmetic Plastic, Laser, Reconstructive Surgeon
Medical Director – DHI India, Medical Director – CPLSS

He always saw himself becoming a best surgeon. Even as a child growing up in Mumbai, India, Dr. Viral Desai always dreamt of becoming a doctor. He grew up in a family of doctors – all specialists in their respective fields. His father, Dr. Ramesh Desai, was a Radiologist and Sonologist; Dr. Sarla Desai, his mother, is a Gynaecologist and Obstetrician.

Dr. Desai charted his dream and graduated from medical school (MBBS) from L.T.M.M. College, Sion. He then joined residency in General Surgery and Oncosurgery at Tata Hospital, KEM Hospital and Cooper Hospital. Soon thereafter, he took up the Super-Speciality in Plastic Surgery (M.S.) course at Sir J. J. Group of Hospitals, Mumbai, for the sheer gratification of beautifying lives through aesthetic surgery and “promptly visible results” offered by plastic surgery.

With a desire to be on par with the world’s best, Dr. Desai completed a fellowship in Advanced Cosmetic and Aesthetic Surgery and Laser Training at Singapore with Dr. Woffles Wu – a teaching faculty with the International Aesthetic Surgery Society and the inventor of the Stealth Incision for breast implant. Dr. Wu is renowned for refining various surgical procedures such as liposuction, chin implants, nose jobs, lip sculpting and eyelid surgeries and has invented over ten cosmetic surgery procedures. Dr. Desai took up a fellowship in the Cosmetic Surgery Department at Singapore General Hospital, where he worked with nine cosmetic surgeons and gained from their vast experience.
While working with Dr. Wu, Dr. Desai has fine-tuned the art of various surgical procedures such as Liposculpting, Breast Implants, Eyelid Surgeries, Nose Jobs, Chin Implants, etc. Dr. Viral Desai is today an advanced BOTOX and Fillers user and trainer in India, and has the distinction of performing the maximum number of Botox and Fillers procedures over the latest few years. He also is the pioneer of Non-Surgical Facelift (WAPTOS), Threadlift (APTOS) in India. Dr. Desai has conducted various training workshops in Advanced Botox and Fillers for doctors and has been a faculty for lectures at various medical and non-medical fraternity gatherings.

Dr. Desai is known for communicating with his patients to understand their real needs. “I talk to them at length to get a grasp of what they want”. He likes to screen his patients for “realistic expectations”, and is being prompt to tell patients if their expectations are unrealistic. He believes in giving his patients accurate and complete information of the procedures. Dr. Desai developed his sense of aesthetic surgery as a natural extension of his interest in art and drawing – having done Elementary and Intermediate courses in Art. Most important in a plastic surgeon, he feels, are “common sense and a good artistic inclination”.Dr. Desai is the Medical Director of CPLSS Mumbai and the founder, promoter and Medical Director of DHI in India. All DHI doctors in India are trained and certified by Dr. Desai. He is also the Director of Sarla Hospital and ICU and of Desai Hospitals Pvt. Ltd. In recognition of his achievements in the field of plastic and cosmetic surgery, Dr. Desai was awarded the Icon of Plastic and Cosmetic Surgery in India Award in 2010 at the national level.

Dr. Desai is a board-certified surgeon, M.Ch. (Masters Super-speciality Degree) and D.N.B. (Diplomate of National Board) in Cosmetic and Plastic Surgery. These are the highest level of education degrees in the medical field. The D.N.B. qualification is recognized across all Commonwealth nations.

Dr. Desai is member of International Society of Aesthetic Plastic Surgery (ISAPS), Association of Plastic Surgeons of India (APSI), Indian Association of Aesthetic Plastic Surgeons (IAAPS), CSI, Maharashtra Association of Plastic Surgeons, Consultants Association of India, Indian Medical Association (IMA), Santacruz Medical Association, General Practitioners Association and other associations.

About Pharma Leaders Super Brand Awards


Pharmaleaders Power Brand Awards are the most prestigious annual industry awards, recognized annually that acknowledge and honor individuals and organizations for their remarkable accomplishments. These set of awards are widely acclaimed in the industry circle as   fitting tribute to those individuals and companies that have gone the extra mile to advance the excellence in healthcare through best practices, initiatives,dynamism,drive & towering  leadership. Pharmaleaders Business Leadership Awards are the premier largest business and technology leadership awards program in the sub continent , covering the set of prestigious awards spanning from biotech to Healthcare to CEO awards. Pharma Leaders Power Brand Awards are conferred to those Companies & Individuals who exhibit rare display of innovation for Outstanding Academic & Professional Leadership to individuals & Companies. This top recognition symbolizes the best out of best from chosen few.

Over the last one decade, since the institutionalization of recognizing excellence in healthcare & pharmaceutical business in the form of Pharmaleaders Business Leadership Awards , Pharmaleaders,  has recognized successful individuals and organizations that have empowered the healthcare industry in the global map by creating values & manufacturing prowess. These Pharmaleaders and organizations inspire the public by motivating others to carry out their calls to action, by serving as a champion for their cause and by demonstrating a clear record of accomplishment in addressing urgent, relevant and complex healthcare needs , problems & solutions. They also maintain consistent, long-lasting relationships with the people and communities in which they work. They are truly trendsetters. Thus the Annual Pharmaceutical Leadership Summit &Pharmaleaders Business Leadership Awards conducted years after years, are truly India’s only dedicated celebration of excellence in healthcare innovation, pharmaceutical & medical excellence and brand transformation. Most eagerly awaited annual affair in india, these set of awards reflect benchmark of credibility, leadership spirit & regarded by the industry experts as “Pharmaleaders Power Brands & now Super Brands.

 

 

 

 

 

Pharma Leaders Super Brand Awards Conferred to Nation’s Top Healthcare Leaders

Pharma Leaders Super Brand Awards Conferred to Nation’s Top Healthcare Leaders. Huzaifa Khorakiwala of Wockhardt, Varun Khanna of BD India, Emcure Pharma, Akumentis Healthcare,Koye Pharma, Bajaj Allianz,Abbott India among others shined at Pharma Leaders 8th Annual  Awards 2015

The 8th Annual Pharmaceutical Leadership Summit & Business Leadership Awards was successfully concluded at the financial capital of india in Mumbai at Hotel Hilton today where more than 300 top leaders of the healthcare industry had gathered to be the part of the historic debate on  “Pharma Leaders 2015, Brand India Winning”. Widely acclaimed in the healthcare industry as the pioneer in recognising the leaders of today & tomorrow, Pharma Leaders brought together veteran healthcare leaders under one plattform. The leadership Summit in the afternoon session debated crucial topics such as Healthcare Insurance, Medical Tourism, Challenges of Indian Pharma Industry. Hinduja Hospital CEO Mr. Gautam Khanna debated on the challenges of Indian Healthcare Insurance while Padma Sree Prof Dr. Shashank Joshi addressed on Brand India. 

Satya Brahma, founder of Pharmaleaders in the opening address lambasted the union government for the faulty healthcare reforms & policy paralysis. In a scathing attack to the policy makers, Satya said “the Healthcare Challenges in India at present are of different dimensions & more of cleaning the system at the helm who are responsible for formulating laws, rules & regulations. While we can’t ignore the concerns of the pharma companies facing complex issues in regulatory legal hurdles in IPR challenges, pricing &other issues related to patent regime. Pharmaleaders believe that the evolving global and domestic market dynamics are likely to result in significant opportunities and challenges for pharma companies operating in India, both Indian companies as well as Indian affiliates of MNC companies. Some key issue areas are already starting to capture the attention of leadership teams within the industry.

The highlight of the seminar was the panel discussion on “Will Innovations in India drive the next generation of global cosmetics Dermatology trends ?” where country’s top doctors & industry debated on the latest innovations in the cosmetic Dermatology field. The panellists argued that the skin care category is going to be the  the next  big business area of the sector the world over & hence the industry will have a unique opportunity to see the latest technologies in this segment, presented by companies from different countries at the forthcoming in-cosmetics also the treatment process of the Cosmetic Dermatologists. India is considered by many as a hotbed of innovation. However, innovating successfully in India is far from easy. But, as we debate Breakthrough Innovation & Path-Breaking Treatment Process, success is rooted in three core principles of Demand-driven Innovation: demand-driven insight, demand-driven development, and pervasive leadership. Noted Plastic and Cosmetic Surgeon Dr. Viral Desai, Dr Manoj Khanna,Dr. Rashmi Shetty, Dr Nilyini G, Ms. Kiren Shrivastav, of Molecule Communications were among those part of the brainstorming session.

Addressing the industry leaders & leading faces of the medical profession, Mr. Louis Banks who has often  been referred to as the Godfather of Indian Jazz & the iconic music composer was the Chief Guest of the evening conferred to top achievers of the country & urged the industry to provide affordable medicines to the common masses in india.

The Evening Award ceremony was marked by the presence of the top business leaders, Industry stalwarts, politicians, eminent healthcare leaders, medical professionals.

The award Winners are :

Social Entrepreneur of the Year 2015

Dr. Huzaifa Khorakiwala, CEO, Wockhardt Foundation

India’s Most Promising & Valuable Company 2015

Jenburkt Pharmaceuticals Limited

Change-Agent in Healthcare Innovations 2015

Adroit Biomed Ltd

Pharmaleader of the Year 2015

Mr. Prakash Kumar Guha, Managing Director, Zuventus Healthcare  Limited

India’s Most Admired Health Insurance Company of the Year 2015

Bajaj Allianz Health Insurance Company Ltd

CEO of the Year 2015

Mr. Tapan Singhel, CEO & MD, Bajaj Allianz General Insurance Company Ltd

Mr. Varun Khanna, Managing Director, Becton Dickinson India  Private Limited 

Innovative Breakthrough in Cancer Research & Patients Safety 2015

Emcure Pharmaceuticals Ltd

Emerging Company of the Year 2015

Koye Pharmaceuticals Pvt  ltd

India’s Most Watched Company of the year 2015

Akumentis Healthcare Ltd

Most Promising Expert in Regenerative Medicine 2015

Dr. Deepak Chaturvedi, Physician Endocrinologist, Diabetologist

Innovative Breakthrough in Side-Effect-Free Healthcare Solution  Provider 2015

Advanced Vital Enzymes Ltd

India’s Most Promising Hair Transplant Surgeon 2015

Dr. Viral Desai, Medical Director & Founder, DHI Hair Transplant

India’s most Admired Plastic & Cosmetic Surgeon 2015

Dr. Viral Desai, Plastic & Cosmetic Surgeon

Asia’s Most Valuable & Breakthrough Innovator in Cardio Thoracic  & Vascular Surgery 2015

Dr. Kaushal Pandey, Cardio Thoracic and Vascular Surgeon

Most Valuable & Admired Hospital 2015

Hinduja Hospital and Medical Research Centre

India’s Most Admired Medical Technology Company of the year

Becton Dickinson India Private Limited

Change-Agent in Women’s Healthcare

The Good World Foundation

India’s Most Inspiring Women Business Leader in Cosmetic  Dermatology 2015

Dr. Chytra. V. Anand, Founder & Chief Medical Director Kosmoderma

Innovative Cosmetic Dermatologist 2015

Dr . Nilayini G, Founder, Blu Skin & Cosmetology Clinic

Most Promising & Valuable Communication Agency 2015

Molecule Communications Pvt. Ltd

Physician’s First Choice as Most Valuable & Admired Pharma  Company 2015

Abbott India Limited

Most Promising Sexual Health Physician and Counselor 2015

Prof. Dr Deepak K Jumani

Emerging Brand of the Year 2015

CARIPILL

Lifetime Achievement Award

Prof R. D. Joshi

Breakthrough Innovation in Facial Plastic Surgery

Dr. Debraj Shome

Most Valuable & Admired Cosmetic Dermatologist 2015

Dr.Rinky Kapoor

India’s Most Promising & Valuable Nutrition & Wellness  Centre in Diet & Nutritional Counseling 2015

Slim Sutra Slimming and Yoga Wellness Centre

Breakthrough Innovation in Cosmetic Dermatology

Dr. Rashmi Shetty

Excellence in Clinical Pharmacology & Medico- Marketing

Dr. Dilip Pawar

Emerging Anti-Aging  & Obesity Management Pharma Company

AVI Pharma Pvt. Ltd

India’s Most Admired Hair Transplant Surgeon 2015

Dr. Manoj Khanna

Company of the year 2015

Wallace Pharmaceuticals Ltd

Noted Plastic & Cosmetic Surgeon Dr. Viral Desai to address on “Patients First in Healthcare : the challenge of creating a new and improved Medicare”

Award Winning Plastic & Cosmetic Surgeon Dr. Viral Desai is al set to floor the delegates at the Asia’s most awaited healthcare Summit, the Pharma Leaders 2015 Summit which is debating on Brand India Winning theme. Dr Desai will be throwing lights on the state of affairs of the Indian healthcare system.

Widely perceived by the industry Leaders, Healthcare Professionals, Policy Makers, Pharma Leaders 2015 edition too will have a significant brand thrust in view of india’s rising power as a top destination for quality manufacturing, research & generic drugs. Announcing the 8th edition of Pharmaleaders Summit & Awards, Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders said ” Pharma Leaders 2015 theme will deliberate on Brand India & its winning spirit as a global power, growing at a growth rate of 13 to 14th % per Annum, the Pharmaceutical Market in India is ranked 3rd in terms of volume and 10th in  terms of market value & clearly the industry is showing the signs for a bigger space in the world market. The issue within India however has complex issues as the key to any reforms & growth are attributed to a strong internal healthcare focus which has many challenges. Healthcare Insurance, access, reach & affordability remain key challenges in india due to a lack of a universal healthcare policies where the patients should be the real beneficiary in any system said Satya Brahma in the news release.

The health system in India today is a mishmash of successes and failures.
The successes

  • India has successfully gone polio free;
  • The forecast for the health care industry in India is very bullish. The industry has been growing at 12% and is expected to be around US 240 Billion by 2020. This means an average compounded annual growth rate of over 20%.  The key drivers will for foreign investment, medical tourism, demographics, economic growth and GoI promotional policies like tax holidays & investment in tertiary care institutions.

The challenges

  • Urban India is showing rapid increase in lifestyle diseases like cardiovascular complaints, diabetes and cancer.
  • Rural India is seeing a sharp increase in non-communicable life style diseases like Respiratory Tract Infections.
  • Poor in urban and rural India are faced with communicable diseases like tuberculosis, Sexually Transmitted Diseases (including HIV/AIDS), dysentery and typhoid.
  • Access to health services is severely limited as health infrastructure proves to be grossly inadequate. This is especially acute in the rural areas where secondary and tertiary care is available with great difficulty.

My views on healthcare reforms

  • Realignment of approach to public health – move away from top-down programmes to respond to demands of the people;
  • Independent monitoring of performance of the Public Health System;
  • Increased investment in secondary and tertiary care, especially in rural &peri-urban areas;
  • Stronger laws to identify and deal with unlicensed practitionersthat wreak havoc in absence of a decent health care system;
  • Open out the medical insurance sector – make it easily available and affordable; extend group insurance policies for the poor (this has started in some States) and also make the sector accountable for its practices and policies.

Dr. Viral Desai is among India’s leading plastic and cosmetic surgeons. He is a qualified M.S., M.Ch, and DNB, and has successfully transformed the lives of his patients for nearly a decade and a half. He is the founder and Medical Director of DHI India, the world’s best technique for hair restoration. He is assisted by a team of super-specialist doctors. CPLSS is among the most premium clinics in India in terms of surgical technique, facilities and in-clinic experience. It is the preferred clinic of celebrities from across the fields of glamour, business, sports and politics. Every field needs role models and so does medicine. A doctor can become a role model usually by publishing in renowned journals, becoming an expert in a specific area, to or by teaching peers at medical conferences. Dr. Viral Desai has achieved all these milestones at a relatively young age. With an excellent academic background, Dr. Viral Desai started his career at a time when there were many misconceptions surrounding plastic surgery. With each passing day, Dr. Desai strove to educate his patients about the intricacies of cosmetic surgery and demonstrate his expertise of the craft at the operating table. Today, after about 15 glorious years of practice, Dr. Viral Desai stands out as the doctor who is most trusted by celebrities and the common man alike for his dedication to the case of his trade and for the excellent results that he continues to deliver in the field of plastic and cosmetic surgery.His dedication and determination to apply himself to the cause of his calling makes Dr. Viral Desai a role model not only to his own team of doctors, but also to doctors and medical students across India.

While working with Dr. Wu, Dr. Desai has fine-tuned the art of various surgical procedures such as Liposculpting, Breast Implants, Eyelid Surgeries, Nose Jobs, Chin Implants, etc. Dr. Viral Desai is today an advanced BOTOX and Fillers user and trainer in India, and has the distinction of performing the maximum number of Botox and Fillers procedures over the latest few years. He also is the pioneer of Non-Surgical Facelift (WAPTOS), Threadlift (APTOS) in India. Dr. Desai has conducted various training workshops in Advanced Botox and Fillers for doctors and has been a faculty for lectures at various medical and non-medical fraternity gatherings.

Dr. Desai is known for communicating with his patients to understand their real needs. “I talk to them at length to get a grasp of what they want”. He likes to screen his patients for “realistic expectations”, and is being prompt to tell patients if their expectations are unrealistic. He believes in giving his patients accurate and complete information of the procedures. Dr. Desai developed his sense of aesthetic surgery as a natural extension of his interest in art and drawing – having done Elementary and Intermediate courses in Art. Most important in a plastic surgeon, he feels, are “common sense and a good artistic inclination”.Dr. Desai is the Medical Director of CPLSS Mumbai and the founder, promoter and Medical Director of DHI in India. All DHI doctors in India are trained and certified by Dr. Desai. He is also the Director of Sarla Hospital and ICU and of Desai Hospitals Pvt. Ltd. In recognition of his achievements in the field of plastic and cosmetic surgery, Dr. Desai was awarded the Icon of Plastic and Cosmetic Surgery in India Award in 2010 at the national level.

 

In India, an estimated 20-40 percent of maternal deaths in India are due to anaemia.Pharma Leaders Brand India Winning to focus on the issue

In India, an estimated 20-40 percent of maternal deaths in India are due to anemia.Globally, anaemia affects 1.62 billion people, which corresponds to 24.8% of the population. The highest prevalence is in preschool-age children (47.4%), and the lowest prevalence is in men (12.7%). However, the population group with the greatest number of individuals affected is pregnant women (41.8%) [3]. In women, anaemia may become the underlying cause of maternal mortality and perinatal mortality [4]. Nearly 50 per cent of women of reproductive age and 26 per cent of men in the age group of 15-59 years are anaemic. South Asia has some of the highest rates of anemia worldwide. At 72 percent, women in the Eastern region of India have a significantly higher prevalence of anemia than the Western states, which estimates 45 percent affected.In addition, a large number of Indian women suffer from anemia throughout the entirety of their lives. The deficiencies can start with low birth weight infant females and worsen during adolescence with the onset of menstruation. Pregnancy further worsens and taxes an already anemic body. Although a plethora of epidemiologic studies have been conducted on anemia in India, National Family Health Surveys and District Level Household and Facility Surveys have proven most useful in tracking the rate of anemia nationally.

Women and children from Eastern India are statistically shown to have higher risk factors for developing anemia. Social class, residence, age, and marital status all play indirect roles in anemia’s prevalence.

Not surprisingly, high socioeconomic status lowered the risk of anemia in all demographics. Education, exposure to mass media, and consumption of milk, milk products, fruits and fish were other protective factors.Statistics also show that low-income urban women and adolescent married women had the highest chances of being anemic.In practical terms, low-income households suffer due to a lack of available resources, such as access to high-quality foods or medicines.

 

Culturally, there is also an inherent attitude towards providing for the males in the family first. This leads to girls and women being given leftovers or food less nutritional in value, especially if resources are limited in a family or community.According to the World Health Organization (WHO), if the community prevalence of anemia is greater than 40 percent, it is considered a high magnitude issue. Although both international and national development campaigns have sought to decrease the anemia burden in India, the real issue is the nutritional status of women throughout their lifespan.

The correlation of anemia and other nutritional deficiencies in this case seems extremely high. My mother—despite being educated as a dietician, from a higher socio-economic class, and someone who consumed a lot of milk and milk products until recently—has been anemic for most of her life. She was a little over a 100 pounds when she gave birth to a healthy, female baby, though she had to make a conscious effort to boost her appetite during her pregnancy. She has spent the majority of her adult life in the United States and not in India, and has remained anemic, on and off, despite how well she eats and maintains her body. It seems to be a childhood deficit that she has not been able to overcome despite her concerted efforts.Indian women in India are at a much greater risk for anemia, women everywhere are likely to be impacted by anemia throughout their lives.It is important to realize that proper nutrition is a life-long process, not a fad diet or one pill fix-all.From statistics, studies, and personal experiences with anemia, it seems clear that the overall nutritional status needs to be enhanced from the beginning of the life cycle.For example, in the current model, an anemic mother gives birth to an underweight female infant, who then becomes anemic as she grows up, and the beginning of menstruation further exacerbates the deficiency. That same anemic woman then goes through pregnancy, which further causes stress, and may lead to another infant who is anemic.It would be easier to narrow the focus of preventative measures to provide proper pre-natal care to pregnant women or to enhance the nutritional resources available to infants, as these are vital developmental stages. Maintaining an overall standard of nutrition, however, is more important and sizably more difficult throughout all stages of life.

 

Modi in Paris for Climate Change, Indian Healthcare System in ICU, What Next?

Mr. Prime Minister What happened to The Draft National Health Policy 2015?

At present about 80 per cent of the medical expenditure in India is paid out-of-pocket by patients and their families. It has resulted in 63 million people facing poverty every year due to healthcare costs resulting from lack of financial protection. India’s medical education system is one of the largest in the world. The 381 medical colleges in the country produce about 45000 doctors annually

According to Indian Medical Journal’s 2013 report, our country needs about 600,000 more doctors. Doctor Patient ratio in India is the root of the problem. We need to build at least 100 times more medical colleges in India. It is time we start thinking about this sector from economic point of view. More supply of Doctors means more competetion, that in turn means quality improvement and low cost. As long as we prevent a few big health insurance companies taking over the entire sector and establishing monopoly, we will remain in good shape. I think increasing MBBS seats is the first step to create healthy competition in this sector. Imagin every village with 5 doctors, who cares if 2 of them are incompetent? They will be out of business in short time. Another thing is to enforce mandatory exams in every two years to keep ours Doctors updated.

 

Pharma Leaders 2015 Edition to debate on “Brand India Winning”

Pharma Leaders 2015 Edition to debate on  “Brand India Winning”

World Healthcare Leaders set to redefine Healthcare Reforms at 8th Annual Pharmaceutical Leadership Summit &Pharmaleaders Business Leadership Awards 2015

The healthcare industry is in the midst of a turbulent global transformation. Healthcare reform policy &  fiscal restraint are some of the biggest challenges  on the minds of politicians, the media and business leaders around the world. The stage is set for a larger consolidation of the pharma sector in india valued at approx 93,000 Crore (INR)  market with a significant presence &  impact in the world. It is evident that the healthcare costs around the world are increasing. In 2013, the total global healthcare spend was $7.2 trillion, or about 11 percent of the world’s gross domestic product. This figure is set to climb more than 5 percent a year for the next few years. In the U.S., costs are expected to rise to $4.8 trillion by 2021& in india however, the situation is complex as india is yet to make landslide healthcare reforms. Prime Minister Narendra Modi, who swept to power at elections last year in May, promised in his poll manifesto to introduce an ambitious universal health care plan that assures free drugs and insurance for serious ailments. But the plan, pegged initially at $26 billion over the next four years and envisioned to be fully operational by 2019, has been pushed back because of budget constraints. Busy with political arithmetic’s, the plan may take a back stage making the cost of the healthcare spending by the poor a toll as 70% of the expenses are still going from the pockets of the common man making life much miserable. To add to the woes are the challenges of the drug companies who are facing the heat of the regulators as ncreasing number of Indian pharmaceutical firms have come under the knife of US Food and Drug Administration (FDA) due to lack of trained staff and cleanliness at their manufacturing units. Against the backdrop of the above summary, Pharmaleaders, Asia’s most analytical news media in healthcare communication is hosting its 8th edition in Mumbai on Wednesday, the 30th December 2015 under the theme “Brand India Winning “at the 8th Annual Pharmaceutical Leadership Summit & Pharma Leaders Business Leadership Awards 2015.

Widely perceived by the industry Leaders, Healthcare Professionals, Policy Makers, Pharma Leaders 2015 edition too will have a significant brand thrust in view of india’s rising power as a top destination for quality manufacturing, research & generic drugs. Announcing the 8th edition of Pharmaleaders Summit & Awards, Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders said ” Pharma Leaders 2015 theme will deliberate on Brand India & its winning spirit as a global power, growing at a growth rate of 13 to 14th % per Annum, the Pharmaceutical Market in India is ranked 3rd in terms of volume and 10th in terms of market value & clearly the industry is showing the signs for a bigger space in the world market. The issue within India however has complex issues as the key to any reforms & growth are attributed to a strong internal healthcare focus which has many challenges. Healthcare Insurance, access, reach & affordability remain key challenges in india due to a lack of a universal healthcare policies where the patients should be the real beneficiary in any system said Satya Brahma in the news release.

Pharmaleaders ( www.pharmaleaders.tv) , a division of Network 7 Media Group ( www.network7mediagroup.net) in association with several trade & industry associations will be focusing on some of the burning issues  confronted by the industry including the much talked about regulatory hurdles & pricing. Top Industry Leaders, Medical practitioners & Policy Makers will be debating in panel discussions to find the reasons of policy paralysis & the way forward. More than 300 leaders from the healthcare industry are expected to attend the 2015 Pharma Leaders Annual Summit including delegations from overseas companies & scientists mostly from Europe.

The much awaited Pharma Leaders Annual Awards will be presented to the top & successful companies & leaders by an eminent panel of Jury Members from the Network 7 Media Group Panel in as many as 40 categories. Pharma Leaders Awards Grand Jury is comprised of a panel of international industry experts,  representing the top creative minds in the field of healthcare, pharma academia, policy formation & the representatives from the  government. Pharma Leaders Awards are credible & independent & enjoy the tag of excellence in innovations in healthcare practice that aim to recognize the remarkable achievement of the companies & Leaders. The 2015 Awards will have significant thrust on initiatives, innovations & insight said the news release.


For Registration, Please contact

Dreamz Integrated Marketing & Communications

Unit No.47, 2nd Floor, Aditya Industrial Estate,

Behind Evershine Mall,Devrukhkar Wadi,Chincholi Bunder Road, Malad (W),Mumbai–400064.

Phone-1 : + 91 22 42481276

Mr Anish Khan : ++ 91 9819499475

anish@dreamzimc.com

Ms Anuja : ++ 91 9920686239

anuja@dreamzimc.com

 

 

 

 

Bangalore based Surana Group of Institutions voted as “Top Management Institute” & Archana Surana as “India’s Most Valuable Woman Educationalist & Reformist” at ILC Power Brand 2015

Bangalore based Surana Group of Institutions voted as “Top Management Institute” & Archana Surana as “India’s Most Valuable Woman Educationalist & Reformist” at ILC Power Brand 2015

Network 7 Media Group Jury recognizes mentorship of Archana Surana in Nation building through reforms & Educations, awards as “India’s Most Valuable Woman Educationalist & Reformist of the year 2015” & Surana College as “Most Promising & Valuable Business Management Institution 2015”.

It was a double celebration at the Bangalore based Surana Group of Institutions at the historic 6th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2015 organized by the illustrious Network 7 Media Group ( www.network7mediagroup.com  , the flagship media outfit Indian Affairs (www.indianaffairs.tv) , Asia’s Most Definitive & Credible News Media in Mainstream Journalism as Surana Group of Institutions under the inspiring, dedicated leadership & mentorship of the Trustees Archana Surana &Dilip Surana,  was recognized as “Most Promising & Valuable Business Management Institution 2015” & its mentor & chief evangelist Archana Surana was unanimously voted by the eminent jury of the Network 7 Media Group as “India’s Most Valuable Woman Educationalist & Reformist of the year 2015” in Mumbai on 18th September at Hotel Sahara Star in a glittering & power packed attendance of more than 300 Leaders of the country who had gathered to witness the powerful lectures on Brand India at 68 years of Independence. The annual edition of Network 7 Media Group currently in its 6th year attracted the attention of top Business Leaders, Politicians, Social Activists, Women Leaders, Movie Stars & Rebel Leaders who participated the daylong seminar & award presentation ceremony.

The Chief patron & Managing Trustee  of the  Surana Group of colleges Archana Surana received the award in person for both the coveted & prestigious titles where more than top 35 Leaders & Organizations were recognized & awarded. The glittering award ceremony saw the presence of Celebrities such as Govinda with wife Sunita Ahuja, Sanjay Khan, Zarine Khan, Ayesha Shroff who had gathered to see the award ceremony where Tina Ahuja, Govinda’s daughter was voted as Emerging Actress of the Year while Ayesha & Jackie Shroff’s son Tiger Shroff received the Promising Actor award at the 6th Annual India Leadership Conclave & Awards 2015. Farah Ali Khan received the prestigious Innovative Leadership in Luxury Brands Concept 2015 while South Actress & Mass queen Ragini Dwivedi received the Promising Actress Award. Archana Surana while receiving the Trophy & Certificates said “This Award & recognition bears testimony of our continued pursuit of seeking excellence in education & motivates us to scale up greater heights in coming days”. Archana Surana dedicated the awards to all the well-wishers, students, staff & those who has been part of the momentous journey of Surana College since inception founded by late visionary leader G.C.Surana.  

Satya Brahma, Chairman, India Leadership Conclave, Dr. Mukesh Batra, Chairman Dr. Batras & Bollywood Star Govinda conferred the awards in more than 35 categories. “The real focus & areas that the juries looked at in 2015 Entries are innovations, initiatives & impact. Network 7 Media group is known for break the rules & stereotype conventions in traditional methodology as it often ignores the faceless Indians but the face of innovations.” The selection of Archana Surana & Surana Group of Institutions are the result of an extensive process & methodology that included innovations, creativity & forward looking approach of the Leadership & the Institutions. The honour recognizes the remarkable accomplishments of Archana Surana as a torch-bearer of the college & one of India’s most Valuable Woman Educationalist & Reformist, Said Satya in a release.

How can we fix India’s broken system & fix bugs in the policy? – India@58

In the endless list of policy prescriptions made by the pundits after the declaration of the general election results there has been precious little commentary on possible judicial reforms despite a near national consensus that our judicial system is broken. This is a rather surprising state of affairs given the lost decade of judicial reforms under the UPA government. On the rare occasion that the national conversation veers towards the topic of clearing the pendency backlog, the ideas under discussion are rather uninspiring. Suggestions for evening courts or fewer court holidays fail to understand the fundamental problems with the Indian judicial system.

INDIA has been growing steadily richer in recent years, but it still has more malnourished people, especially children, than any other country. A big, nationwide study from 2005 and 2006, the National Family Health Survey (NFHS), found that 42.5% of children under five years old were underweight. The region with the next highest proportion of underweight children is Africa, with an average of 21%. Another measure of malnutrition is stunting, when children are unusually short for their age. Again, India’s problems were shown to be unusually bad.

Now comes some good news. In 2013 and 2014 the UN agency for children, Unicef, and India’s government conducted a new study called the Rapid Survey on Children (RSOC). The purpose was to gather up-to-date figures to use in the interim before the next big NFHS survey, which is under way. The RSOC report has unfortunately not been published, but The Economist obtained a copy.

It points to some striking national trends. For example the proportion of underweight children has fallen from 42.5% a decade ago, to just under 30% now. There have been similar improvements on stunting, wasting and other measures of malnutrition. The national immunisation rate has risen and the rate of open defecation is down from 55% of households to 45%.

Really interesting, however, is the breakdown of results by state, presented here. By and large social and health indicators across India follow predictable patterns. In states with higher incomes, those nearer the coast and farther south, most health indicators are better. Typical high achievers are Kerala and Tamil Nadu. In landlocked states, poorer ones and in the north, social and health results are usually worse. Notorious backward states include Bihar and Uttar Pradesh. North-eastern states are often outliers, both poor and landlocked but often with high rates of literacy and better health.

Results from the RSOC mostly bear out these trends. Everywhere has seen a reduction in the share of underweight children and in stunting. But it is striking that on occasion higher incomes do not correlate with the biggest health gains. Maharashtra and Gujarat are both states with relatively prosperous people, but Maharashtra’s nutrition levels are better than Gujarat’s. This is also true for rates of immunisation and of open defecation. It appears that Maharashtra’s government has put more emphasis on tackling nutrition problems, for example among its adivasi, or tribal, population.

Two crucial factors are worth looking at. Lower rates of open defecation correlate well with reduced malnutrition. When children live and play in clean environments they are less likely to be infected with parasites that make it hard to absorb nutrients. And states that focus on helping girls and young mothers probably do better at breaking long-term cycles of malnutrition. Where teenage girls have a low body-mass index there seems a greater likelihood mothers will give birth to undernourished children. Proper nutrition for girls and women should be a priority.

Pendency is only one issue facing the Indian judiciary. The more substantial issues concern the quality of justice and accountability. Both these issues are inextricably linked to the lack of transparency in almost all aspects of the judiciary’s functioning and there is precious little that is being done to remedy the situation.

As the RTI Act has demonstrated, transparency can dramatically alter the status quo in powerful institutions because as Justice Brandies once commented “sunlight is said to be the best of disinfectants” and the Indian judiciary needs a lot of sunlight. Unfortunately, as will be explained below, the Indian judiciary has almost excluded itself from the ambit of the RTI Act.

Accountability through statistics

Let’s start with the issue of statistics on case pendency and judicial backlog. There is no single database in the country which collects statistics regarding various aspects of pending cases in each and every courtroom of India. In 2004 eminent lawyer and Senior Advocate Mr. Fali S. Nariman who was then a MP in the Rajya Sabha introduced in Parliament the Judicial Statistics Bill, 2004. This proposed legislation was aimed at creating authorities at the national and state level to collect, in a scientific manner, statistics from each and every courtroom regarding the hours taken by the Court to hear the dispute, the time between the filing of the case and hearing by the court, the adjournments granted, time taken for delivery of judgment after it has been reserved, along with the names of the lawyers and judges responsible for the case. Imagine the possibilities if all this data was made available on a computerized database. Not only would it provide information on the efficacy of the judges but also help litigants separate the litigating lawyers from the adjournment lawyers. (Frontline carried an interesting story on the bill over here.)

Nariman’s intention of introducing such a bill was to help in better data collection so as to facilitate a better study of the judiciary but was against using it as a tool of accountability. In his interview to Frontline, he said “I don’t like confrontation with the judiciary. The objective is to try and discern whether anything can be done better by inspiring judges and lawyers. The Bill cannot be a new source of litigation. A citizen, if properly motivated, can use the statistics, provide for himself a mechanism and an opportunity to get greater inputs than what is now available, to do something without the fear of contempt.”

Notwithstanding Nariman’s stand, the true value of this data collected through the Judicial Statistics Bill, 2004 was the tremendous impact that it would have on judicial accountability because once statistics on the functioning of courts are placed in the public domain it is only a matter of time before policy wonks can track trends and publicly separate the inefficient courtrooms from the efficient court rooms. Unfortunately for India, the UPA lacked the vision to enact this bill.

For far too long the judiciary has taken refuge under the cloak of judicial independence to avoid any accountability

The judiciary’s battle against the RTI

The battle for greater transparency in the internal workings of the judiciary should have strengthened after the enactment of the Right to Information Act. Unfortunately, judicial attitudes to the RTI Act, especially that of the Supreme Court’s Registry, have been rather hostile. Three cases highlight the judicial ‘hostility’ to the RTI Act.

In the first case, when a RTI activist filed an application with the Supreme Court, in 2007, asking for disclosure of the assets of all Supreme Court judges the Registry of the Supreme Court fought the RTI applicant all the way to the Delhi High Court which ordered the Supreme Court Registry to disclose the information in 2009. (The judgment can be read here) Even then the Supreme Court Registry appealed to the Supreme Court itself but after a revolt in the ranks the list of assets were made public. The appeal to the Supreme Court is yet to be decided.

In the second case, a RTI activist Commodore Batra, had filed a RTI application with the Supreme Court asking for the number of cases reserved by its judges for judgment between 2007 and 2009. The Supreme Court Registry refused to provide such information on the grounds that it did not maintain such records. The Central Information Commission (CIC) over-ruled the Supreme Court Registry on August 3, 2011 and ordered the Registry to provide the information to the applicant. Instead of conceding to the CIC, the Supreme Court filed an appeal before the Delhi High Court in 2011 and the matter has been pending since then.

The third case involves the applicability of the RTI Act to legal pleadings and other public documents held by registries of various courts. Even before the RTI Act, the internal rules of most courts across the country allowed for litigants to access pleadings held by the registry. The difference between the internal rules of these Courts and the RTI Act is that the latter provides for a delightfully simply mechanism to access the information. On the other hand, accessing information under the internal rules of the court is complicated and out of bounds for most common people who will have to conduct the process through a lawyer or a court clerk. Most courts across the country, including the Registry of the Supreme Court have flat out rejected the applicability of the RTI Act to access pleadings that are otherwise available under the internal rules of the Court.

In contradictory decisions, two different commissioners of the CIC came to diametrically opposite conclusions. The CIC judgment ordering the Supreme Court Registry to make available even pleadings under the RTI Act has been appealed to the Delhi High Court by the Registrar of the Supreme Court in 2011 and the appeal continues to languish before the High Court.

Forcing transparency on the judiciary

Like all powerful institutions the judiciary isn’t going to volunteer more information about itself because it is well aware that increased transparency will make it more vulnerable to criticism. At times, arguments have been made that increased transparency will impinge on judicial independence. However such arguments need to be dismissed with contempt.

As Nariman stated in his interview with Frontline “Judicial independence means deciding cases without being influenced by anybody. But disseminating information about how many cases get decided in the courts will not compromise judicial independence at all. This is a wrong impression that the judiciary, among all organs of the government, must remain totally secretive, and nobody must know anything that is happening in the judiciary.”

For far too long the judiciary has taken refuge under the cloak of judicial independence to avoid any accountability.

Parliament must enact the Judicial Statistics Bill, 2004 along with amendments to the RTI Act to force the judiciary to be more transparent.

A long-awaited report on electoral reforms issued by India’s law commission has failed to introduce a ceiling on poll spending by parties, perhaps the most serious lacuna in the country’s political system, because it gives a huge advantage to those supported by the wealthy.

 The report, released last week, has retained the ceiling on what individual politicians can spend in their constituency at between Rs54 lakh and Rs70 lakh, with the exact value depending upon the size of the electoral area. But in the absence of a cap on what parties as a whole can spend to promote themselves before an election, these limits on individual expenditure will make only a slight difference in creating a level-playing field for all parties.
  In the 2014 general election, the Bharatiya Janata Party (BJP), which swept to victory, spent Rs714 crore and the ousted Congress spent Rs516 crore, according to the data the parties filed with the election commission. All parties must file this information within 90 days from the last day of polling. But one estimate pegs the BJP’s spending just on advertising at seven times the total official amount, of around Rs5,000 crore.
 The law commission, an executive body set up to advise the government on legal reforms, has, however, attempted to improve disclosures on the sources of funding—perhaps the next-most important electoral reform, one linked to overall transparency in the political process. The Association of Democratic Reforms, a non-partisan advocacy group, estimates that nearly three-fourths of national parties’ total income now comes from unknown sources.
 

The main loophole with disclosure was the fact that while parties had to reveal to the election commission the names of donors who gave amounts greater than Rs20,000, they did not have to do so for smaller sums. In order to avoid disclosure, parties therefore often broke up larger donations from one source into parcels of less than Rs20,000.

 But the report has now clarified that parties must reveal the identity of an entity or individual who donates more than Rs20,000 in all. This means parties cannot resort to the sleight of hand of passing off big donations from one source as smaller ones.
 Moreover, parties will now have to reveal sources of donations even if they are less than Rs20,000 each in denomination if the total funds collected in these smaller amounts crosses Rs20 crore or 20% of the parties’ total income, whichever is less.
 The Bahujan Samaj Party, for example, has used this loophole for eight years in a row. In 2013, it declared that it had received Rs307.31 crore from voluntary contributions between 2004 and 2013, but did not disclose any of the donors’ names, claiming that none of the amounts was more than Rs20,000.
 

Stricter penalties

Parties will attract heavier penalties for not filing information or not doing so on time. If the election commission finds a party to have wilfully filed wrong information, it can now levy a fine of up to Rs50 lakh.

 A candidate who fails to file the necessary information within 90 days after the end of a general election can be barred for five years from contesting an election—instead of three previously. The fine for political parties who fail to file information on time will be Rs25,000 per day, up from Rs10,000, and they could also lose tax benefits.
 

Given that none of the major parties filed expenditure statements on time after the 2014 general elections, these higher penalties could help. The deadline to file expenditures was August 26, 2014, but the two major parties—the Congress and the BJP—filed their expenses only in December and January, respectively.

World Renowned Facial Plastic & Oculoplastic Surgeon Dr. Debraj Shome voted as “India’s Most Promising Face in Facial Plastic Surgery Innovations” at ILC POWER BRAND 2015

World Renowned Facial Plastic & Oculoplastic Surgeon Dr. Debraj Shome voted as “India’s Most Promising Face in Facial Plastic Surgery Innovations” at ILC POWER BRAND 2015

Celebrity Plastic Surgeon known for path-breaking Facial Surgery storms into the 6th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2015 as the innovative Facial Plastic Surgeon. Voted as Leader in medicine of tomorrow in facial cosmetic & reconstructive surgery.  

 MediAngels  Founder & noted Facial Plastic Surgeon, Dr. Debraj Shome has been relentlessly batting for building a world-class online healthcare platform & make healthcare available to very Indian equitably and affordably & is is my dream and this goes beyond my ‘other hat’ as a Facial Plastic Surgeon is what the eminent Plastic Surgeon & Oculoplastic Surgeon said on the eve of the forthcoming Leadership Meet organised by Indian Affairs, the flagship brand of Network 7 Media Group, Asia’s most credible media in mainstream journalism hosting its 6th edition in Mumbai on 21st Augst 2015 . India@58 is the theme at 6th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2015  where Nation’s burning issues from world leaders, industry icons, Politicians, movie stars, rebels, peacemakers and social activists will be addressing.

Network 7 Media Group while announcing the name of , Dr. Debraj Shome for the selection to the category “India’s Most Promising Face in Facial Plastic Surgery Innovations” at ILC POWER BRAND 2015, the jury members looked at the revolutionary approaches in Facial Surgery by the top Facial Plastic Surgeon & Oculoplastic Surgeon who also finds a special mention at Part of “Marquis Who’s Who” & voted amongst “Best Plastic Surgeons in India” by multiple agencies. The US returned Plastic Surgeon has been in limelight recently for his opinions that almost 44% of the 12,500 patients for whom surgery was recommended were advised against it by their second opinion consultants.

In a letter addressed to MediAngels  Founder Dr. Debraj Shome congratulating his selection for the coveted title as “India’s Most Promising Face in Facial Plastic Surgery Innovations”, Satya Brahma, Chairman & Editor-In-Chief of Network 7 Media Group said, “ I appreciate the spirit of innovations & path-breaking initiatives that you have been fostering over the years in medical research in Cosmetic Surgery. I am fully convinced of your accomplishments as one of the torch-bearers of cosmetic and reconstructive surgery, an investigator whose novel work will evolve the treatment of surgical disorders and the practice of plastic surgery, though not in full sense of the term, to foster the development of the best new technology and inventions in the field of plastic surgery. It is indeed commendable. We also looked at your  dedicated to enhancing natural beauty, using state-of-the-art procedures to achieve natural results designed to make patients feel better and more confident about their appearance special in recent times when patient expectations often going beyond the limits of what doctors can control.  I can clearly see that as an Editor & being connected to high profile celebrities, this is indeed a bigger challenges, I can say with confidence, that your practice is unique, much will be seen may be in 2020. India Leadership Conclave Platform only gives credence & recognition to innovators. The previous healthcare leaders in medical practice include Dr. Ramakant Panda, Dr. Mukesh Batra, Dr N.S. Laud, Dr. Shashank R Joshi, Dr. Naresh Trehan, Dr. Kaushal Pandey, Dr. Mukesh Hariawala to name a few”, Satya added.

Dr. Debraj Shome is the Co-Founder and currently heads the Institute of Aesthetic Surgery – The Esthetic Clinics, at JCI accredited top-line multi-specialty Indian corporate hospital. He is presently attached to many multi-specialty hospitals including Breach Candy Hospital (Breach Candy, Mumbai, India), Saifee Hospital (Girgaon, Mumbai, India), Nova Specialty Hospital (Chembur, Mumbai, India) and Holy Family Hospital (Bandra, Mumbai, India). He is the head of the Facial Plastic Surgery center at Nova superspecialty surgery, Chembur, Mumbai, India. This is one of the topmost centers catering to ultra-superspecialty surgery in India.He was the co-founder of the Esthetic Clinic at Apollo Health City, Hyderabad, and had been the Head of the Department of Facial Plastic & Cosmetic Surgery there from 2009-2011.

Dr. Shome is a world renowned and an acclaimed Facial Plastic Surgeon & Oculoplastic Surgeon, who specializes in facial cosmetic & reconstructive surgery, Oculoplastic surgery, ocular & facial cancers, orbital, lacrimal & socket surgery and is one of a handful Indian surgeons listed by Wikipedia, the world’s largest online encyclopedia (http://en.wikipedia.org/wiki/Debraj_Shome). Dr. Debraj Shome has won many citations and honors such as “Best Plastic Surgeon Mumbai”, “Top 10 Cosmetic Surgeon India”, “Best Oculoplastic Surgeon India”, “Marquis Who’s Who”, “Celebrity Plastic Surgeon in World”, “Marquis Who’s Who Asia Pacific” etc. Oculo-Facial Plastic Surgery is a burgeoning super-specialty in India, but is quite in demand in the USA currently. Currently majority of the facial surgeries in the US are performed by this particular group of plastic surgeons, who are super-specialized in surgeries of the lacrimal, orbital, facial & peri-ocular tissues. As these surgeons have been trained specifically in plastic surgery of the tissues of the face & practice exclusively in the face, end results in all facial surgeries tend to be better than general plastic surgeons who operate all over the body.

Dr. Debraj Shome’s special interests include Cosmetic Facial Plastic Surgery, Oculoplastic Surgery, Non-surgical Facial Rejuvenation, Face Lifts, Mid-Face lifts, Facial Reconstructive Surgery post Facial fractures & cancers, Rhytidectomy (wrinkle removal), Blepharoplasty (eyelid lifts), Eyelash enhancement, Rhinoplasty (Nose job), Auricular (ear) Repositioning (Otoplasty), Hair Transplants and Hair Restoration Surgery, Facial & Orbital Fracture Repairs, Neck Lifts, Jaw Contouring, Reconstructive Surgery for Facial & Eyelid Cancers, Facial implants (Chin & Cheek implants) for re-shaping the face or changing the facial contour in order to look more young and beautiful, Lip Augmentation & enhancement, Facial Flaps & Grafts for Facial Cancers, Orbicularis Oculi Myectomy for intractable Hemifacial spasm & Blepharospasm, Eyelid Surgery viz. Ectropion, Entropion, Ptosis surgery, False eye (Artificial Prosthetic Eye) fitting & Socket Surgery (Evisceration, Exenteration, Enucleation), Ocular Anterior Segment Trauma and Reconstruction (surgery post injury to the eye), Orbital Tumor Surgery & Orbitotomy (Medial, Lateral, Anterior & Complex), Orbital Decompression Surgery, Lacrimal Surgery for watering of eyes & tear duct blockage surgery (Dacrocystorhinostomy, Endoscopic Lacrimal Surgery, Dacrocystectomy, CDCR, Nasal Intubation, Probing & Syringing) and Ocular Oncology (eye cancer therapy like treatment for malignant melanoma, retinoblastoma, skin cancers, orbital lymphoma, basal cell carcinoma, etc.)

Since June 2007, Dr. Shome has been a Visiting Faculty to the Department of Head and Neck Surgery at the M D Anderson Cancer Center, Houston, TX, www.mdanderson.org. Earlier he was also attached to Aditya Jyot Eye Hospital Pvt. Ltd. Mumbai, India (One of India’s top eye hospitals) and the Tata Memorial Center, Mumbai. His responsibilities included – conceptualizing, developing the Department of Oculoplastic Surgery (Ophthalmic Plastic Surgery) & Facial Plastic Surgery and being the Head Of Department there. These centers had been extremely successful. Apart from his clinical insight, Dr. Debraj Shome has a research background with interests in basic science as well as clinical plastic surgery & ophthalmology and has published more than 40 international scientific peer-reviewed papers and presented papers at various scientific forums.

Dr. Debraj Shome acquired his undergraduate medical degree from Grant Medical College and Sir J.J. Group of Hospitals, Mumbai; one of India’s oldest medical schools. Thereafter, he went ahead to specialize in ophthalmology and completed his residency from Sankara Nethralaya, Chennai. He obtained the degrees of F.R.C.S. (Fellow of Royal College of Physicians and Surgeons of Glasgow) in 2003 and also his Diplomate of National Board (D.N.B.) in 2004. Dr. Shome then studied extensively and acquired specialization degree in Orbital surgery, Ocular Oncology & Ophthalmic Plastic Surgery in an elaborate fellowship from L.V. Prasad Eye Institute, Hyderabad, India, 2005. Dr. Shome subsequently completed an esteemed clinical fellowship in Cosmetic Facial Plastic surgery from one of the world’s top centers at the University of Utah, Salt Lake City, USA. Following that, Dr. Shome completed another clinical Fellowship in Head & Neck Surgery from the Department of Head & Neck Surgery at the M D Anderson Cancer Center in 2007. This fellowship, prepared Dr. Debraj Shome to specialize in multi-disciplinary approaches to Head & Neck Oncology. This makes Dr. Shome truly distinctive as he has been trained independently and exclusively at the best / top centers in ophthalmology (eye surgery), plastic reconstructive & cosmetic surgery of the face & peri-ocular area & oculoplastic surgery. After completing his MBA (Masters of Business Administration) in Healthcare Management in November 2008, from one of the world’s top business schools, Dr. Shome added another chef d’oeuvre. Such a remarkable coalition of top-class health and clinical practice skill sets enables Dr. Shome to develop and lead teams to make the best possible centers, as a man manager, an administrator and a surgeon. Dr. Debraj Shome founded The Esthetic Clinic at Apollo Hospitals Hyderabad, now situated at two of the most reputed hospitals in Mumbai. Dr. Debraj Shome has won numerous rewards and honors in his career till date. He has penned down more than 40 research papers and has published those in top-line peer reviewed international journals, chapters in international books and has given numerous presentations in ophthalmology conferences, head & neck conferences, oculoplasty meetings, ENT conferences, Reconstructive Surgery meets, Facial Plastic Surgery Conferences, Plastic Surgery symposiums, and Cosmetology conferences all over the world; thus, Dr. Shome is a trailblazer who not only practices the best in medicine but also conducts research that modify practice patterns and make up the ‘medicine of tomorrow’.

Indian Affairs Editor-In-Chief Mr. Satya Brahma caught up with Dr. Debraj Shome on the recent state of affairs in the field of Plastic Surgery, here are the excerpts from the interview.

Question: What according to you is Facial Plastic Surgery trending now?

Answer : This is the era of super-specialization in Medicine. As Doctors become super-specialized, they gain even more knowledge in that particular specialty which they are specialized in. This, in turn, improves medical outcomes.

In earlier days, there used to be just general practitioners and they who used to treat all kind of disease conditions, affecting any and every part of the human body.  For example, Earlier, it used to be the case that our kids used to get treated by a Family Physician. But now, with so much advancement and super-specialization in the field of Medicine, every parent would prefer taking their child to Pediatrician (Child Specialist) for treatment. In general, it has been proven repeatedly as Doctors keep on doing the same thing again & again, their outcomes improve, which in turn benefits the patients.

This concept of improved results with super-specialization, extends itself to Facial Plastic Surgery. Earlier, there used to be only General Plastic Surgeons and they used to perform all types of plastic surgery on the entire body and also surgeries as varied as microvascular surgery, burns surgery, hand surgery and even aesthetic facial plastic surgery. But, it is impossible for any one specialist to excel in all of these types of surgeries. This marked the start of the advent and development of Facial Plastic Surgery as a super-specialty.

In the Western world, it has been proven repeatedly that when a Facial Plastic Surgeon performs a surgery on the face, as opposed to a General Plastic Surgeon, the outcomes of surgery are much improved. A Facial Plastic Surgeon’s sole focus is performing surgeries on the face. They keep on doing the same types of surgeries throughout their life, as a result of which there are improved outcomes & lesser complications.

Cosmetic Surgery or Plastic Surgery is all about trying to make a person look better & perform a surgery in an aesthetic manner, whatever be the underlying cause, be it fracture, cancer, or purely for cosmetic reasons. It is unacceptable in today’s world to be treating a cancer on the face in a manner that the cancer is treated, but the face is scarred for life! So, paying aesthetic attention to all diseases of the face, is important!

So, in summary, If Doctors start concentrating on a particular part of body, e.g face, certainly the results will be better and patients will have more predictable outcomes. So, Facial Plastic Surgery is currently a growing sub-specialty in India, but a standard specialty in the US and any other Western countries. In western countries, most of the surgeries of the face are performed by Facial Plastic Surgeons and I see this trend being reproduced in India over a period of time.

Question : Has India come of ages in the Creative & substantive innovations in Facial Plastic Surgery if so, what are its milestone achievements?

 Answer : Facial Plastic Surgery is an emerging specialty in India. Most of the Facial Plastic Surgeons in India today, have been trained in this specialty from across the world and are now practicing in India. This is beneficial to India, as I am certain that these surgeons will bring with them the expertise of the Western world, outcomes will start improving and becoming better and better as individuals and professionals concentrate on this particular branch of medicine.

India is already turning out to be a large Medical Tourism centre for people from the western countries coming here to get treated. Indian doctors have created a name for themselves in multiple specialties & sub-specialties. It seems as if Facial Plastic Surgery would be the next frontier.

Some milestone achievements have been achieved by us so far, in Facial Plastic Surgery, already. Like for example, in 2010, we were responsible for treating an Iraqi woman, whose face was destroyed by a pen bomb planted by the American Forces. It took us 11 hours to reconstruct all the bones of her face and give her a new look and a new life. This was probably the first Face Transplant like Surgery or the first complete Face Rejuvenation Surgery performed in India. Many such milestone achievements would be expected from Indian Facial Plastic Surgeons in the future, as there is no paucity of talent in India.

This story was covered globally by Reuters.

Question : Your take on Indian VS Global in excellence in Facial Plastic Surgery?

Answer : The face is a cross over zone and there are a multiple specialities, who perform surgeries on the face. For an instance, there are General Plastic Surgeons who operate on the face. There are Oculoplastic Surgeons, who are from an Ophthalmology background and work on the face & are specialized to work in the area in and around the eyes & upper face. There are Facial Plastic Surgeons who are from an ENT (Otolaryngology) & sometimes Ophthalmology and work on the face; Maxillofacial Surgeons who come from a background of Dentistry and are specialized to treat bones and occlusion. Each of these backgrounds gives these surgeons greater understanding in their areas of the face. So, I think it becomes very important to gain excellence in Facial Plastic Surgery by trying to work with all these multiple specialties, and to learn from each of them.

People who get to work with all these multi-specialties tend to get better because there is something to learn from every other surgeon they are working with. An ENT surgeon would perform a better Rhinoplasty (Nose job) surgery when trained in Facial Plastic Surgery, or an Ophthalmologist would be better at performing a Blepharoplasty (Eyelid Surgery) and so on. And someone who has worked with all these specialties will certainly create excellence.

I am very privileged to have gained Fellowship training (additional surgical training) in 4 different & diverse sub-specialties associated with Facial Plastic Surgery which are, Head & Neck Surgery, Oculoplastic Surgery, Facial Plastic Surgery & I recently completed a Fellowship training in Cranio-Maxillofacial Surgery from Wales, UK.  By training with multiple specialties, it helps to amplify our knowledge and lets us get better.

When comparing Indians with Global excellence in Facial Plastic Surgery, I can say that at this moment India is in an emergent stage when it comes to Facial Plastic Surgery. Probably there a very few trained Facial Plastic Surgeons. However, this trend is set to change since all the surgeons are realising that we cannot be performing surgeries for all the parts of the body and excel at it all. So in the near future, I see more and more Indians training in Facial Plastic Surgery, concentrating on excelling in this, publishing research papers in Facial Plastic Surgery and working towards making India one of the Global frontiers in Facial Plastic Surgery.

Question : What according to you are the missing links in Indian Facial Plastic Surgery?

 Answer : In my opinion, the biggest missing link in Indian Facial Plastic Surgery is that there are no programs or training courses dedicated to training young surgeons in Facial Plastic Surgery in India. Most of the current Facial Plastic Surgeons have been trained overseas.

In India, when Doctors acquire training in Plastic Surgery, they feel that obtaining a M.Ch. in General Plastic Surgery is the best possible way to become a Plastic Surgeon. But the truth is that, M. Ch. Training courses in General Plastic Surgery in Indian hospitals do not even deal with Cosmetic Surgery. They deal chiefly with burns & reconstructive surgery. Now, when you are trained in burns surgery and try to come and try and operate on a person’s nose and change it 1 mm this way or that way, these are really different surgeries to perform.  And, even more difficult patients to manage. The mindset itself of managing these patients and performing these surgeries is very different!

So, doctors/ surgeons like us who are trained in different specialties should come together and start training programs in India, so that more and more surgeons are ultimately trained in & specialised in Facial Plastic Surgery. The surgical skills are already there, what needs to happen is more and more surgeons should be trained in terms of appropriate communication for a cosmetic patient, developing the right mindset and obtaining appropriate training in Facial Plastic Surgery. This will certainly help transform India into one of the Global frontiers for Facial Plastic Surgery.

Question : Describe yourself as a person, a Plastic Surgeon & a Global Citizen.

Answer : Facial Plastic Surgery is a super-specialty that is shooting up in India presently while in USA, it is in vogue currently and most facial surgeries in US currently are performed by this particular genre of plastic surgeons, who are super-specialized in surgeries of the facial tissues.

I was the ex-Head of Department at the Institute of Aesthetic Surgery at The Apollo Hospitals, Apollo Health City, Hyderabad, India and Ex-Consultant at the Institute of Aesthetic Surgery at Fortis Hospital, Mumbai, India which are both JCI accredited top-line multi-specialty Indian corporate hospitals.

My interests include Plastic surgery, cosmetic & reconstructive surgery, aesthetic and cosmetic surgery, facial plastic & reconstructive surgery. I chiefly deal with Cosmetic Facial Plastic Surgery, Facial Plastic & Reconstructive Surgery post face fractures and cancers, Non-Surgical Facial Rejuvenation, Rhinoplasty (Nose Job / Nose Surgery), Face lifts, Mid-Face lifts, Mini Facelift, Rhytidectomy (wrinkle removal), Auricular (ear) repositioning (Otoplasty), Hair transplants and hair restoration surgery, Eyelash enhancement,  Neck Lifts, Blepharoplasty (eyelid lift / cosmetic eyelid surgery), Lip Augmentation and shaping, Jaw contouring, Facial Fracture repairs, Aesthetic Surgeries for Facial Cancers, Facial Implants (for changing the shape of the face), Facial Myectomies for intractable Blepharospasm & Hemifacial Spasm, Facial Flaps & Grafts for face cancers, etc.

I am privileged to be one of very few Indian surgeons listed by Wikipedia (http://en.wikipedia.org/wiki/Debraj_Shome).

I consider myself very fortunate to have won numerous accolades and honors in my career till date. I have to my credit, 40 research articles published in top-line peer reviewed international journals, chapters in international books and numerous presentations in ophthalmology conferences, head & neck conferences, ENT conferences, Facial Plastic Surgery Conferences and Cosmetology conferences world over. Also, I am honoured to be a faculty at two of the world’s top rhinoplasty and facial plastic surgery cadaveric dissection courses, held at Vinnea, Austria and San Francisco in USA.I am extremely fortunate to have won the Colonel Rangachari award & the Hanumantha Reddy award in 2010, for a revolutionary paper and invention of a nano-molecule of carboplatin (a cancer drug), which promises to change the way eye, facial & neural cancers are treated. This is considered the highest award for research performed in ophthalmology in India that year. As a Global Citizen,  I would like to see that healthcare becomes available equally and freely for all. Apart from being a Physician, I have also had the honour of being entrepreneurial and we have started an Online Hospital called MediAngels.com . MediAngels.com aims to do to healthcare, what Flipkart & Snapdeal are doing to products all over the world.  The purpose of this e-healthcare venture is to have the best doctors from all across the world on a cloud based platform and match the best Doctor to every single disease with the help of technology, in the form of phone and the internet, and making doctors available all across the world.It seems strange to me and surreal in a way that in the population of about 1.2 billion in India, you can buy the best phone or camera whether you are in the most remote area or in Mumbai, but you still can’t have access to the best doctors. Today, you cannot have access to the best doctors and I am sure the same would be the case 30 years later, as best doctors are a rare resource, and it would be very difficult to have the best doctors in every city or every town or every village or every multi-specialty hospital.Therefore, MediAngels, the World’s First Online Hospital, is the business of tomorrow, wherein we connect Global Medical experts, diagnostic laboratories and all other types of medical requirements, to patients, using technology. The strength of MediAngels can be ascertained by the fact that it has been voted as the most innovative startup in the Asia Pacific region in 2012, by Intel & The Department of Science & Technology, Government of India, from amongst 8,000 companies. The strength of this social enterprise can also be deciphered from the fact that MediAngels has been funded by diverse entities, like the India’s largest private equity fund – HDFC Holdings Ltd., the Department of Science & Technology, Government of India and by a renowned venture capital fund – VenturEast.So in summary, I as a Global Citizen would like to change the way healthcare is delivered all across the world. I, in my lifetime, would like to see an equitable distribution of healthcare to every citizen in India & all over the world, at the most affordable price, within the comforts of their office/ workplace. MediAngels is our way of trying to accomplish the same. We hope to succeed in our endeavour to do so!

References:

http://en.wikipedia.org/wiki/Debraj_Shome

http://www.theestheticclinic.com/about/doctors/debraj-shome.html

http://www.debrajshome.com/

https://in.linkedin.com/in/drdebrajshome

https://www.youtube.com/user/drdebrajshome